Vertex Pharmaceuticals Inc
Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –
Vertex Pharmaceuticals PSUs by Year
PSUs — Weighted-average grant-date fair value of nonvested shares ($/sh) ($)
Vertex Pharmaceuticals PSUs: $413 in FY2025, up 19.2% from a year earlier. That is the highest of the 10 years on record here.
Where the FY2025 figure comes from
Source: Form 10-K (filed 2026-02-13) ↗
Reported in Form 10-K Note (Stock-based Compensation — PSU Rollforward).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | PSUs — Weighted-average grant-date fair value of nonvested shares ($/sh) ($) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 413 | +19.2% | Form 10-K (filed 2026-02-13) ↗ |
| FY2024 | Dec 31, 2024 | 346 | +40.0% | Form 10-K (filed 2026-02-13) ↗ |
| FY2023 | Dec 31, 2023 | 247 | +9.0% | Form 10-K (filed 2025-02-13) ↗ |
| FY2022 | Dec 31, 2022 | 227 | +5.0% | Form 10-K (filed 2024-02-15) ↗ |
| FY2021 | Dec 31, 2021 | 216 | +6.8% | Form 10-K (filed 2023-02-10) ↗ |
| FY2020 | Dec 31, 2020 | 202 | +41.1% | Form 10-K (filed 2022-02-09) ↗ |
| FY2019 | Dec 31, 2019 | 143 | +29.6% | Form 10-K (filed 2021-02-11) ↗ |
| FY2018 | Dec 31, 2018 | 111 | +26.2% | Form 10-K (filed 2020-02-13) ↗ |
| FY2017 | Dec 31, 2017 | 87.59 | -3.8% | Form 10-K (filed 2019-02-13) ↗ |
| FY2016 | Dec 31, 2016 | 91.05 | – | Form 10-K (filed 2018-02-15) ↗ |
Cite this data
StockData. (2026). Vertex Pharmaceuticals PSUs ($), annual FY2016–FY2025 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/psu-nonvested-wafv
See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.